After treatment with various concentrations of matrine (0.75, 1.5, and 2.0 g/L) for 24 h, the expression levels of Bcl-2 decreased while the expression levels of Bax increased in AML cell lines as well as primary AML cells. Here, BCL2 is linked to acute myeloid leukemia.